# SUTENT

NDC: 63539-019
Generic name: Sunitinib malate
Labeler / Manufacturer: U.S. Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20060126

FDA application: NDA021938

## Active ingredients

- SUNITINIB MALATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63539-019"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63539-019
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5d555f5-d66a-4f94-abcf-96fa6d71a32f